Table 1.
Current status of vaccine development for horses and dogs
| Species | Company | Technology | Vaccine | Antigens | Vaccine strain |
|---|---|---|---|---|---|
| Dogs | MERCK | Whole inactivated sub-unit | Nobivac Canine Flu H3N8 | Whole virus | Not assigned |
| Zoetis | VANGUARD CIV H3N8 | Whole virus | A/canine/Iowa/9A1/B5/08/D12 (H3N8) | ||
| Zoetis MERCK | Canine influenza vaccine, H3N2 (conditionally licensed) | Whole virus | A/canine/Illinois/12191/2015 (H3N2) | ||
| Horses | Elanco | Whole inactivated sub-unit | Duvaxyn IE Plus | Whole virus | Newmarkert/1/93 (H3N8) |
| Suffolk/89 (H3N8) | |||||
| Prague/56 (H7N7) | |||||
| Boehringer Ingelheim Animal Health | Calvenza-03 EIV | Whole virus | Newmarkert/2/93 (H3N8) | ||
| Kentucky/2/95 (H3N8) | |||||
| Oiho/03 (H3N8) | |||||
| MSD Animal Health | Equilis Prequenza (updated 2013) | Whole virus | Newmarket/2/93 (H3N8) | ||
| South Afirica/4/03 (H3N8) | |||||
| MSD Animal Health | Equilis Prequenza | Sub-unit HA | Prague/56 (H7N7) | ||
| Newmarkert/1/93 (H3N8) | |||||
| Newmarkert/2/93 (H3N8) | |||||
| Pfizer Ltd. | Equip F | Sub-unit mainly HA and NA | Newmarkert/77 (H7N7) | ||
| Borlänge/91 (H3N8) | |||||
| Kentucky/98 (H3N8) | |||||
| Intervet/Schering-Plough Animal Health (USA) | Modified live EIV | Flu Avert I.N | Whole virus | Attenuated, cold adapted EIV: Kentucky/91 (H3N8) | |
| Merial Animal Health Ltd. | Viral-vector based | PROTEQ FLU | HA | Ohio/03 (H3N8) | |
| Newmarket/2/93 (H3N8) | |||||
| Merial Animal Health Ltd. | PROTEQ FLU (updated 2014) | HA | Ohio/03 (H3N8) | ||
| Richmond/1/07 (H3N8) |
Modified from Paillot R. Vaccines (Basel) 2014;2:797-831 [41], according to the Creative Commons License.
EIV, equine influenza virus; HA, hemagglutinin; NA, neuraminidase.